BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18462163)

  • 1. Maternal HLA homozygosity and mother-child HLA concordance increase the risk of vertical transmission of HIV-1.
    Mackelprang RD; John-Stewart G; Carrington M; Richardson B; Rowland-Jones S; Gao X; Mbori-Ngacha D; Mabuka J; Lohman-Payne B; Farquhar C
    J Infect Dis; 2008 Apr; 197(8):1156-61. PubMed ID: 18462163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections.
    John GC; Nduati RW; Mbori-Ngacha DA; Richardson BA; Panteleeff D; Mwatha A; Overbaugh J; Bwayo J; Ndinya-Achola JO; Kreiss JK
    J Infect Dis; 2001 Jan; 183(2):206-212. PubMed ID: 11120927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal human leukocyte antigen A*2301 is associated with increased mother-to-child HIV-1 transmission.
    Mackelprang RD; Carrington M; John-Stewart G; Lohman-Payne B; Richardson BA; Wamalwa D; Gao X; Majiwa M; Mbori-Ngacha D; Farquhar C
    J Infect Dis; 2010 Oct; 202(8):1273-7. PubMed ID: 20812845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load.
    Dickover RE; Garratty EM; Herman SA; Sim MS; Plaeger S; Boyer PJ; Keller M; Deveikis A; Stiehm ER; Bryson YJ
    JAMA; 1996 Feb; 275(8):599-605. PubMed ID: 8594240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent effects of nevirapine prophylaxis and HIV-1 RNA suppression in breast milk on early perinatal HIV-1 transmission.
    Chung MH; Kiarie JN; Richardson BA; Lehman DA; Overbaugh J; Njiri F; John-Stewart GC
    J Acquir Immune Defic Syndr; 2007 Dec; 46(4):472-8. PubMed ID: 18077838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.
    Mofenson LM; Lambert JS; Stiehm ER; Bethel J; Meyer WA; Whitehouse J; Moye J; Reichelderfer P; Harris DR; Fowler MG; Mathieson BJ; Nemo GJ
    N Engl J Med; 1999 Aug; 341(6):385-93. PubMed ID: 10432323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of HIV-1 Envelope-Specific Breast Milk IgA Responses with Reduced Risk of Postnatal Mother-to-Child Transmission of HIV-1.
    Pollara J; McGuire E; Fouda GG; Rountree W; Eudailey J; Overman RG; Seaton KE; Deal A; Edwards RW; Tegha G; Kamwendo D; Kumwenda J; Nelson JA; Liao HX; Brinkley C; Denny TN; Ochsenbauer C; Ellington S; King CC; Jamieson DJ; van der Horst C; Kourtis AP; Tomaras GD; Ferrari G; Permar SR
    J Virol; 2015 Oct; 89(19):9952-61. PubMed ID: 26202232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 viral load and other risk factors for mother-to-child transmission of HIV-1 in a breast-feeding population in Cote d'Ivoire.
    Jamieson DJ; Sibailly TS; Sadek R; Roels TH; Ekpini ER; Boni-Ouattara E; Karon JM; Nkengasong J; Greenberg AE; Wiktor SZ
    J Acquir Immune Defic Syndr; 2003 Dec; 34(4):430-6. PubMed ID: 14615662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal analysis of human immunodeficiency virus type 1 RNA in breast milk and of its relationship to infant infection and maternal disease.
    Rousseau CM; Nduati RW; Richardson BA; Steele MS; John-Stewart GC; Mbori-Ngacha DA; Kreiss JK; Overbaugh J
    J Infect Dis; 2003 Mar; 187(5):741-7. PubMed ID: 12599047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal viral load and timing of mother-to-child HIV transmission, Bangkok, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group.
    Mock PA; Shaffer N; Bhadrakom C; Siriwasin W; Chotpitayasunondh T; Chearskul S; Young NL; Roongpisuthipong A; Chinayon P; Kalish ML; Parekh B; Mastro TD
    AIDS; 1999 Feb; 13(3):407-14. PubMed ID: 10199232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
    Sperling RS; Shapiro DE; Coombs RW; Todd JA; Herman SA; McSherry GD; O'Sullivan MJ; Van Dyke RB; Jimenez E; Rouzioux C; Flynn PM; Sullivan JL
    N Engl J Med; 1996 Nov; 335(22):1621-9. PubMed ID: 8965861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission.
    MacDonald KS; Embree J; Njenga S; Nagelkerke NJ; Ngatia I; Mohammed Z; Barber BH; Ndinya-Achola J; Bwayo J; Plummer FA
    J Infect Dis; 1998 Mar; 177(3):551-6. PubMed ID: 9498431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human leukocyte antigen (HLA) B*18 and protection against mother-to-child HIV type 1 transmission.
    Farquhar C; Rowland-Jones S; Mbori-Ngacha D; Redman M; Lohman B; Slyker J; Otieno P; Obimbo E; Rostron T; Ochieng J; Oyugi J; Bosire R; John-Stewart G
    AIDS Res Hum Retroviruses; 2004 Jul; 20(7):692-7. PubMed ID: 15307911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal Humoral Immune Correlates of Peripartum Transmission of Clade C HIV-1 in the Setting of Peripartum Antiretrovirals.
    Mutucumarana CP; Eudailey J; McGuire EP; Vandergrift N; Tegha G; Chasela C; Ellington S; van der Horst C; Kourtis AP; Permar SR; Fouda GG
    Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28566336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA Class II Antigens and Their Interactive Effect on Perinatal Mother-To-Child HIV-1 Transmission.
    Luo M; Embree J; Ramdahin S; Bielawny T; Laycock T; Tuff J; Haber D; Plummer M; Plummer FA
    PLoS One; 2015; 10(5):e0126068. PubMed ID: 25945792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal but Not Infant Anti-HIV-1 Neutralizing Antibody Response Associates with Enhanced Transmission and Infant Morbidity.
    Ghulam-Smith M; Olson A; White LF; Chasela CS; Ellington SR; Kourtis AP; Jamieson DJ; Tegha G; van der Horst CM; Sagar M
    mBio; 2017 Oct; 8(5):. PubMed ID: 29066544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding Viral and Immune Interplay During Vertical Transmission of HIV: Implications for Cure.
    Amin O; Powers J; Bricker KM; Chahroudi A
    Front Immunol; 2021; 12():757400. PubMed ID: 34745130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of HLA-G1 at the placental interface of HIV-1 infected pregnant women and vertical transmission of HIV.
    Moodley S; Bobat R
    Placenta; 2011 Oct; 32(10):778-82. PubMed ID: 21816469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia. MRC/Gambia Government/University College London Medical School working group on mother-child transmission of HIV.
    O'Donovan D; Ariyoshi K; Milligan P; Ota M; Yamuah L; Sarge-Njie R; Whittle H
    AIDS; 2000 Mar; 14(4):441-8. PubMed ID: 10770548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort studies. SEROGEST Cohort Group.
    Mayaux MJ; Dussaix E; Isopet J; Rekacewicz C; Mandelbrot L; Ciraru-Vigneron N; Allemon MC; Chambrin V; Katlama C; Delfraissy JF; Puel J
    J Infect Dis; 1997 Jan; 175(1):172-5. PubMed ID: 8985214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.